Ticker Symbol: CELMF

Anagenics Ltd

Exchange: US OTC Country: AU Currency: USD Asset Type: Common Stock

Company Profile

Cellmid Ltd. operates as a biotechnology company, which engages in the development and marketing of therapies and diagnostic tests for inflammatory and fibrotic diseases, cancer, ischemic diseases of the heart, and hair loss. It operates through the following segments: research and development of diagnostics and therapeutics; and research, development and marketing of hair care products. The company was founded on October 8, 2004 and is headquartered in Sydney, Australia.

Sector: Health Technology

Industry: Pharmaceuticals: Major

Standard Industrial Classification Code (SIC code): 2834

Address: 55 Clarence Street

Website: http://www.cellmid.com.au

CEO: Maria Julianna Halasz

Tags:

Biotechnology
Health Technology
Pharmaceuticals: Major

Pricing

Last Updated: December 31, 1969 07:00 PM EST

Previous Close: -

Change: - ( 0.00%)

Days Range: - - -

Beta: -

52wk. High: -

52wk. Low: -

Ytd. Change 0.00%

50 Day Moving Average: -

200 Day Moving Average: -

Shares Outstanding: 221021303

Valuation

Market Cap: -

PE Ratio: -

EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -

Dividend Yield (TTM): 0.00%

Ex-Dividend Date: N/A